Cargando…
Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program
BACKGROUND: Changes in federal policy during the COVID-19 pandemic allowing for the use of telemedicine to treat opioid use disorder (OUD) have facilitated innovative strategies to engage and retain people in treatment. Since 2018, the Baltimore City Health Department has operated a mobile street me...
Autores principales: | Harris, Robert, Rosecrans, Amanda, Zoltick, Meredith, Willman, Catherine, Saxton, Ronald, Cotterell, Margaret, Bell, Joy, Blackwell, Ingrid, Page, Kathleen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619879/ https://www.ncbi.nlm.nih.gov/pubmed/34890927 http://dx.doi.org/10.1016/j.drugalcdep.2021.109187 |
Ejemplares similares
-
Methadone, Buprenorphine, and Street Drug Interactions with Antiretroviral Medications
por: Gruber, Valerie A., et al.
Publicado: (2010) -
The pressing shortage of buprenorphine prescribers and the pending role of telemedicine
por: Molfenter, Todd
Publicado: (2015) -
Low-Threshold Buprenorphine via Community Partnerships and Telemedicine—Case Reports of Expanding Access to Addiction Treatment During COVID-19
por: Levander, Ximena A., et al.
Publicado: (2022) -
Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
por: Wang, Linda, et al.
Publicado: (2021) -
Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder
por: Weintraub, Eric, et al.
Publicado: (2021)